S-cubed Pharmaceutical Services ApS: Financial statements 2020
CVR: 39035448
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
S-cubed Pharmaceutical Services ApS (CVR 39035448) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 145,744 and a net result of DKK 142,229 compared with DKK -206,952 the year before. That is a decrease of 69.3% compared with the year before. Equity in the 2020 report amounted to DKK 149,703. The solvency ratio was 96.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 145,744
- Profit/Loss
- DKK 142,229
- Equity
- DKK 149,703
- Total Assets
- DKK 155,703
- Employees
- 1
Official annual report
How creditworthy is S-cubed Pharmaceutical Services ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
S-cubed Pharmaceutical Services ApS has published its annual report for 2019. Gross profit came to DKK 475,144, and the net result was DKK -206,952.
About S-cubed Pharmaceutical Services ApS
S-cubed Pharmaceutical Services ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2017. The company is registered under the industry Anden teknisk rådgivning. The management consists of Mark Dennis Lipscombe. The company is owned by S-Cubed Limited. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,235 and a net result of DKK -959 compared with DKK -51,181 the year before. Equity in the 2025 report amounted to DKK 599,313.